Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2013
11/21/2013US20130310358 Pyrimidine compounds as delta opioid receptor modulators
11/21/2013US20130310348 Quinoline derivatives and uses thereof
11/21/2013US20130309191 Compounds for the treatment of clostridium difficile-associated disease
11/21/2013DE102012104247A1 New heterocyclic compound, useful in an optoelectronic component such as solar cell, organic LED, organic FET and a photodetector
11/20/2013EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/20/2013EP2480532B1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis
11/20/2013EP2468717B1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
11/20/2013EP2407451B1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/20/2013EP2240443B1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain
11/20/2013EP1709009B1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
11/20/2013EP1572199B1 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
11/20/2013CN103402996A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD)
11/20/2013CN103402994A Heteroaryl derivatives as alpha7 NACHR modulators
11/20/2013CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors
11/20/2013CN103402985A Microbiocidal pyrazole derivatives
11/20/2013CN103402984A Novel kinase inhibitors
11/20/2013CN103402979A Chemical compounds
11/20/2013CN103402511A Novel benzodioxole piperidine compounds
11/20/2013CN103396534A Two-dimensional conjugated quinoxaline polymer and application thereof
11/20/2013CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/19/2013US8586766 Method for producing episulfide compound
11/19/2013US8586764 Organic dyes and preparation method thereof and dye-sensitized solar cells
11/19/2013US8586740 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative
11/19/2013US8586625 Derivatives of taxol and closely related compounds
11/19/2013US8586623 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
11/19/2013CA2746307C Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
11/19/2013CA2707418C Inhibitors of human immunodeficiency virus replication
11/19/2013CA2645110C Pharmaceutical composition for external use
11/19/2013CA2633624C 3,5-substituted piperidine compounds as renin inhibitors
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/19/2013CA2587423C 1-arylpyrazoles and their use as pesticides
11/14/2013WO2013170186A1 Carbazole-containing sulfonamides as cryptochrome modulators
11/14/2013WO2013170115A1 Pyridazine and pyridine derivatives as nampt inhibitors
11/14/2013WO2013170113A1 Nampt inhibitors
11/14/2013WO2013168688A1 Organic electroluminescence element, illumination device, and display device
11/14/2013WO2013168084A1 Optoelectronic components comprising organic hole transport material
11/14/2013WO2013168015A1 Compositions and methods for the treatment of asthma and allergy
11/14/2013WO2013167991A1 Compositions and methods for the treatment of metabolic disorders
11/14/2013WO2013167495A1 Bicyclically substituted uracils and the use thereof
11/14/2013US20130303579 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
11/14/2013US20130303547 HCV Protease Inhibitors and Uses Thereof
11/14/2013US20130303537 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity
11/14/2013US20130303522 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
11/14/2013US20130303520 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
11/14/2013US20130303515 Novel compounds useful for the treatment of metabolic and inflammatory diseases
11/14/2013US20130303510 Nampt inhibitors
11/14/2013US20130303509 Nampt inhibitors
11/14/2013US20130303507 Substituted hetero-biaryl compounds and their uses
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303493 Triazole Compounds that Modulate HSP90 Activity
11/14/2013US20130303492 3,5-diaminopyrazole kinase inhibitors
11/14/2013US20130303491 Antiviral Drugs for Treatement or Prevention of Dengue Infection
11/14/2013US20130303368 New compositions and methods for controlling nematode pests
11/14/2013US20130302378 Matrix metalloproteinase inhibitors
11/14/2013DE102012104118A1 Lochtransportmaterialien für optoelektronische Bauelemente Hole transport materials for optoelectronic devices
11/14/2013CA2873138A1 Compositions and methods for the treatment of local pain
11/14/2013CA2873016A1 Compositions and methods for the treatment of epilepsy
11/13/2013EP2662369A1 benzimidazol-2-yl-phenyl compound, light-emitting element, light-emitting device, electronic device, and lighting device
11/13/2013EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators
11/13/2013EP2661433A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
11/13/2013EP2661426A1 Pyrazol-4-yl carboxamide derivatives as microbiocides
11/13/2013EP2661425A2 Hedgehog antagonists having zinc binding moieties
11/13/2013EP2661424A1 Chemical compounds
11/13/2013CN103391925A 5-halogenopyrazolecarboxamides
11/13/2013CN103389621A Oxime ester sulfonate type photo-acid generator
11/13/2013CN103387567A NEPT compound and preparation method and application thereof
11/13/2013CN103387538A Synthesis method of quinoline derivative
11/13/2013CN102285919B Method for preparing 4-fluorinated pyrazole derivative
11/13/2013CN102203136B Photoinitiator mixtures
11/13/2013CN101918386B 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides
11/13/2013CN101868455B Therapeutic substituted lactams
11/13/2013CN101679279B Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
11/12/2013US8580965 Substituted sulfonamide compounds
11/12/2013US8580834 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/12/2013US8580820 Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
11/12/2013US8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist
11/12/2013CA2607917C Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/12/2013CA2606683C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/12/2013CA2604038C New tricyclic angiotensin ii agonists
11/12/2013CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/07/2013WO2013165192A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013165189A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013164833A1 Improved process for preparing rivaroxaban using novel intermediates
11/07/2013WO2013164337A1 New compounds and new use
11/07/2013WO2013164245A1 Plant growth regulating compounds
11/07/2013US20130296551 7-membered ring compound and method of production and pharmaceutical application thereof
11/07/2013US20130296350 Method of Treatment or Prophylaxis
11/07/2013US20130296333 Hedgehog pathway modulators
11/07/2013US20130296327 Substituted heterocylic compounds
11/07/2013US20130296274 Pyrrolidinones as metap-2 inhibitors
11/06/2013EP2660240A1 Benzopyrone estrogen receptor regulator
11/06/2013EP2658851A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
11/06/2013CN103384712A Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/06/2013CN103384662A Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
11/06/2013CN103382250A Novel episulfide compounds, curable resin compositions containing the episulfide compounds, and cured products thereof
11/06/2013CN103382196A (E)-1-(8-benzopyranyl)-2-allyl-1-one and its analogues, and use thereof
11/06/2013CN103382178A Condensed-cyclic compound and organic light-emitting diode comprising the same
11/06/2013CN103382176A Novel vanilloid receptor ligands and their use for producing medicaments
11/06/2013CN102099350B Novel herbicides
11/06/2013CN101899006B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 523